Antimicrobial Stewardship and Empirical Therapy
On this page
Direct answer
Antimicrobial stewardship is the practice of using antibiotics at the right drug, dose, duration and time, so that infections are treated while resistance and harm are limited. Empirical therapy starts before culture results, chosen from the likely pathogens for the syndrome and the local antibiogram. It is then narrowed or stopped at 48 to 72 hours once cultures and clinical response are known.
What you must remember
- Empirical therapy: chosen by the most likely organisms for the syndrome, the site and the local antibiogram, and started within the first hour in septic shock.
- Cultures first: blood, urine and source samples should be taken before the first dose whenever this does not delay treatment.
- De-escalation: narrow to a targeted agent or stop at 48 to 72 hours after reviewing culture, susceptibility and clinical response.
- Duration: many uncomplicated infections need short courses, and community-acquired pneumonia in a stable patient is commonly treated for about 5 days.
- Resistance drivers: antibiotics for viral illness, broad-spectrum use without indication, prolonged courses and poor infection control in hospitals.
- AWaRe: WHO groups antibiotics into Access, Watch and Reserve, and Reserve agents are kept for resistant infections where other options fail.
- Indian framework: the National Action Plan on Antimicrobial Resistance (first plan 2017, NAP-AMR 2.0 launched in 2025), ICMR treatment guidance and Schedule H1 controls on prescription-only sale support stewardship.
From the first dose to the stop date
Stewardship is a sequence of decisions, and each one either protects the patient or feeds resistance. The route below follows a hospital admission for suspected infection from the first prescription to the discharge plan.
- Identify the syndrome: match the site and severity to the likely organisms, such as community-acquired pneumonia, complicated urinary tract infection or intra-abdominal sepsis.
- Choose the empirical agent: cover the likely pathogens with the narrowest effective drug, using the local antibiogram, and reserve broad-spectrum cover for severe sepsis or a known risk of resistant organisms.
- Send cultures first: draw blood cultures and source samples before the first dose when this does not delay treatment, since a culture taken after antibiotics may come back falsely negative.
- Review at 48 to 72 hours: check culture results, susceptibility and clinical response, then narrow, change or stop the agent based on what the review shows.
- Set the duration: fix a stop date at the outset, using short courses for uncomplicated infections and longer courses for bone, endovascular or undrained collections.
- Plan the discharge: avoid unnecessary oral tails, and write the stop date and the reason for the antibiotic on the discharge summary.
Where the exam tries to catch you
Stewardship questions reward the student who matches the drug to the pathogen and the review point, not the one who reaches for the widest agent. The traps below are the most common errors in this area.
- Trap: giving broad-spectrum antibiotics to every febrile patient until cultures return Correct: start empirical therapy by the likely pathogens, then narrow at 48 to 72 hours, since wide cover without review drives resistance.
- Trap: a full month of antibiotics "to be safe" for pneumonia Correct: many uncomplicated pneumonias in stable patients respond to about 5 days, so longer courses need a specific reason.
- Trap: antibiotics for a viral upper respiratory infection Correct: antibiotics do not act on viruses, so they are withheld unless a bacterial complication is evident.
- Trap: a Reserve agent chosen first for a mild community infection Correct: Reserve antibiotics are last-line options that should be saved for resistant infections.
Frequently asked questions
What is the difference between empirical and definitive antibiotic therapy?
Empirical antibiotic therapy is started before culture and susceptibility results, based on the likely pathogens for the syndrome. Definitive antibiotic therapy is the narrower agent chosen once the causative organism and its susceptibility are known.
When should empirical antibiotic therapy be de-escalated?
Empirical antibiotic therapy should be de-escalated at 48 to 72 hours, once culture results, susceptibility and clinical response are known. De-escalation may mean narrowing to a targeted agent or stopping an antibiotic that is no longer needed.
What does the WHO AWaRe classification mean in antimicrobial stewardship?
The WHO AWaRe classification groups antibiotics into Access, Watch and Reserve categories. Access agents are first-line choices for common infections, Watch agents carry higher resistance potential, and Reserve agents are last-line options for resistant infections.
Why does the local antibiogram matter for empirical therapy?
The local antibiogram shows which organisms are common in a hospital or region and which antibiotics they remain susceptible to. Empirical antibiotic therapy is chosen against these local patterns, because resistance differs widely between hospitals and cities.
Which Indian policy frames antimicrobial stewardship?
The National Action Plan on Antimicrobial Resistance is India's national framework for antimicrobial stewardship; the first plan was published in 2017 and NAP-AMR 2.0 followed in 2025. It is supported by ICMR surveillance and treatment guidance, while Schedule H1 controls prescription-only sale of antibiotics.